Eradication Therapies for HIV Infection: Time to Begin Again

Por Margolis, David M.
Publicado em 2011

Histone deacetylase inhibitors and HIV latency

Por Margolis, David M.
Publicado em 2011

Treatments for persistent HIV infection: the road ahead

Por Margolis, David M
Publicado em 2010

Counterregulation of Chromatin Deacetylation and Histone Deacetylase Occupancy at the Integrated Promoter of Human Immunodeficiency Virus Type 1 (HIV-1) by the HIV-1 Repressor YY1...

Por He, Guocheng, Margolis, David M.
Publicado em 2002

Translational Challenges in Targeting Latent HIV infection and the CNS reservoir problem

Por Garrido, Carolina, Margolis, David M.
Publicado no J Neurovirol (2014)

Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency

Por Choudhary, Shailesh K., Margolis, David M.
Publicado em 2011

Combined approaches for HIV cure

Por Margolis, David M., Hazuda, Daria J.
Publicado em 2013

Emerging strategies to deplete the HIV reservoir

Por Archin, Nancie M., Margolis, David M.
Publicado em 2014

Repression of Human Immunodeficiency Virus Type 1 through the Novel Cooperation of Human Factors YY1 and LSF

Por Romerio, Fabio, Gabriel, Matthew N., Margolis, David M.
Publicado em 1998

Therapy for Persistent HI

Por Keedy, Kara S., Kashuba, Angela D., Margolis, David M.
Publicado em 2010

Framing expectations in early HIV cure research

Por Dubé, Karine, Henderson, Gail E., Margolis, David M.
Publicado em 2014

Detection of Human Immunodeficiency Virus RNAs in living cells using Spinach RNA aptamers

Por Burch, Brandon D., Garrido, Carolina, Margolis, David M.
Publicado no Virus Res (2016)

c-Myc and Sp1 Contribute to Proviral Latency by Recruiting Histone Deacetylase 1 to the Human Immunodeficiency Virus Type 1 Promoter

Por Jiang, Guochun, Espeseth, Amy, Hazuda, Daria J., Margolis, David M.
Publicado em 2007

Latency reversal and viral clearance to cure HIV-1

Por Margolis, David M., Garcia, J. Victor, Hazuda, Daria J., Haynes, Barton F.
Publicado no Science (2016)

Improved Measures of Quality of Life, Lipid Profile and Lipoatrophy after Treatment Interruption in HIV-Infected Patients with Immune Preservation: results of ACTG 5170

Por Skiest, Daniel J., Krambrink, Amy, Su, Zhaohui, Robertson, Kevin R., Margolis, David M.
Publicado em 2008

Therapy for latent human immunodeficiency virus type 1 infection: the role of histone deacetylase inhibitors

Por McManamy, Mary E Manson, Hakre, Shweta, Verdin, Eric M, Margolis, David M
Publicado em 2014

Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid

Por Archin, Nancie M., Espeseth, Amy, Parker, Daniel, Cheema, Manzoor, Hazuda, Daria, Margolis, David M.
Publicado em 2009

Words Matter: Discussing Research Towards an HIV Cure in Research and Clinical Contexts

Por Tucker, Joseph D., Volberding, Paul A., Margolis, David M., Rennie, Stuart, Barré-Sinoussi, Françoise
Publicado em 2014

Eradicating HIV-1 infection: seeking to clear a persistent pathogen

Por Archin, Nancie M., Sung, Julia Marsh, Garrido, Carolina, Soriano-Sarabia, Natalia, Margolis, David M.
Publicado no Nat Rev Microbiol (2014)

A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression

Por Keedy, Kara S., Archin, Nancie M., Gates, Adam T., Espeseth, Amy, Hazuda, Daria J., Margolis, David M.
Publicado em 2009